Meet us at Emergency Conference
SWEET 2017 in Stockholm
SWEET March 23-24, 2017
SWEET is the National Meeting for the Swedish Society of Emergency Medicine.
Visit us at the ViroGates booth where we will be running demos of the suPARnostic® Quick Triage product during the coffee breaks, together with our distributor Triolab!
Please find more information on the program here; SWEET 2017
ViroGates at Emergency Conferences in 2017
In addtion to SWEET in Stockholm, we look forward to meeting you at the following
Emergency Conferences in 2017:
April 28-29, Middelfart, Denmark: DASEM 2017 - Danish Society for Emergency Medicine
May 22-24, Copenhagen, Denmark:EMS 2017- European Emergency Medical Services
June 7-9, Alicante, Spain: SEMES 2017 - Spanish Society of Emergency Medicine
Sept. 23-27, Athens,Greece: EuSEM 2017- European Congress on Emergency Medicine
NEW suPAR Abstracts
"The intriguing role of soluble urokinase receptor in inflammatory diseases"
by S Desmedt et al., Review article, Critical Reviews in Clinical Laboratory Sciences, January 2017.
"suPAR is a novel inflammatory biomarker with high potential. It is a very stable molecule.
The elevated circulating concentration of suPAR is associated with the presence of several inflammatory diseases, the development of fibrosis and with an increased risk of mortality.
The reported findings could have important therapeutic consequences...."
"Soluble urokinase plasminogen activator receptor in one-year prediction of major adverse cardiac events in patients after first myocardial infarction treated with primary percutaneous coronary intervention"
by Rafał N. Wlazełet al. in Archives of Medical Science, August 2016.
"Soluble urokinase plasminogen activator receptor level appears to be an independent useful biomarker for the prediction of major adverse cardiac events early after first myocardial infarction.
The suPAR level assessed at discharge may be a useful independent predictor for cardiovascular events (better than other biomarkers, such as CRP) in patients with the first AMI."